Journal of Cancer Research and Practice (Jun 2014)

Thyroid Storm Provoked by Interleukin-2 Therapy for Metastatic Melanoma

  • Yao-Chung Liu,
  • Ming-Hung Hu,
  • Yuan-Hao Yang,
  • Jyh-Pyng Gau,
  • Jin-Hwang Liu

DOI
https://doi.org/10.1016/S2311-3006(16)30028-3
Journal volume & issue
Vol. 1, no. 1
pp. 75 – 81

Abstract

Read online

With the growing use of immunotherapy in the treatment of cancer and autoimmune disease, severe autoimmune thyroid dysfunction may be provoked at an increasing rate. We herein report a 49-year-old male patient experiencing a life- threatening thyroid storm provoked by interleukin-2 (IL-2). This was a case of pulmonary metastasis of melanoma without a previous history of thyroid dysfunction. For the metastatic melanoma, he underwent combined immunochemotherapy including dacarbazine and IL-2. The 3rd course of immunochemotherapy was complicated with a thyroid storm manifested by high fever, tachycardia and even transient cardiac arrest. Fortunately, he recovered eventually from this crisis by immediate resuscitation followed by antithyroid dugs. Our case highlights the rare complication of a thyroid storm provoked by IL-2 treatment. Precaution against autoimmune thyroid dysfunction is required during treatment with IL-2 and probably also other kinds of newly-developed immunotherapy to avoid life-threatening complications.

Keywords